Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG)

P Pfeiffer; C Rose; B Ejlertsen; M Andersson; D Pedersen; H T Mouridsen

doi:10.3109/02841869609083970

Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG)

P Pfeiffer, C Rose, B Ejlertsen, M Andersson, D Pedersen, H T Mouridsen

Originalsprog	Engelsk
Tidsskrift	Acta Oncologica
Vol/bind	35 Suppl 5
Sider (fra-til)	57
ISSN	0284-186X
DOI	https://doi.org/10.3109/02841869609083970
Status	Udgivet - 1996
Udgivet eksternt	Ja

Adgang til dokumentet

10.3109/02841869609083970

Citationsformater

Pfeiffer, P., Rose, C., Ejlertsen, B., Andersson, M., Pedersen, D., & Mouridsen, H. T. (1996). Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica, 35 Suppl 5, 57. https://doi.org/10.3109/02841869609083970

Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG). / Pfeiffer, P; Rose, C; Ejlertsen, B et al.
I: Acta Oncologica, Bind 35 Suppl 5, 1996, s. 57.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Pfeiffer, P, Rose, C, Ejlertsen, B, Andersson, M, Pedersen, D & Mouridsen, HT 1996, 'Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG)', Acta Oncologica, bind 35 Suppl 5, s. 57. https://doi.org/10.3109/02841869609083970

Pfeiffer P, Rose C, Ejlertsen B, Andersson M, Pedersen D, Mouridsen HT. Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica. 1996;35 Suppl 5:57. doi: 10.3109/02841869609083970

@article{b2cf8d23db674a0eaac40e35f948c935,

title = "Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG)",

keywords = "Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Breast Neoplasms/drug therapy, Cyclophosphamide/administration & dosage, Drug Administration Schedule, Epirubicin/administration & dosage, Female, Fluorouracil/administration & dosage, Humans, Neoplasm Metastasis, Tamoxifen/administration & dosage",

author = "P Pfeiffer and C Rose and B Ejlertsen and M Andersson and D Pedersen and Mouridsen, {H T}",

year = "1996",

doi = "10.3109/02841869609083970",

language = "English",

volume = "35 Suppl 5",

pages = "57",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG)

AU - Pfeiffer, P

AU - Rose, C

AU - Ejlertsen, B

AU - Andersson, M

AU - Pedersen, D

AU - Mouridsen, H T

PY - 1996

Y1 - 1996

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage

KW - Breast Neoplasms/drug therapy

KW - Cyclophosphamide/administration & dosage

KW - Drug Administration Schedule

KW - Epirubicin/administration & dosage

KW - Female

KW - Fluorouracil/administration & dosage

KW - Humans

KW - Neoplasm Metastasis

KW - Tamoxifen/administration & dosage

U2 - 10.3109/02841869609083970

DO - 10.3109/02841869609083970

M3 - Journal article

C2 - 9142967

SN - 0284-186X

VL - 35 Suppl 5

SP - 57

JO - Acta Oncologica

JF - Acta Oncologica

ER -